Sv. Allander et al., CHARACTERIZATION OF THE CHROMOSOMAL GENE AND PROMOTER FOR HUMAN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5, The Journal of biological chemistry, 269(14), 1994, pp. 10891-10898
To better understand the regulation of insulin-like growth factor bind
ing protein-5 (IGFBP-5) expression, we cloned the IGFBP-5 gene from hu
man genomic libraries and identified a region in the 5' flanking seque
nce which functions as a promoter. The human IGFBP-5 gene is divided i
nto four exons which, primarily due to a first intron of similar to 25
kilobases, span similar to 33 kilobases of DNA. Southern analysis ide
ntified a single copy of the IGFBP-5 gene in the haploid human genome,
and several independent mapping strategies found this gene tightly li
nked with, and in opposite transcriptional orientation to, the IGFBP-2
gene at chromosomal region 2q33-34. Primer extension studies identifi
ed the IGFBP-5 mRNA cap site 772 base pairs (bp) 5' to the first nucle
otide of the translation start codon. Analysis of the 5'-flanking sequ
ence identified a potential TATA element beginning 33 bp 5' to the mRN
A cap site. When a DNA fragment containing this cap site and 461 bp of
upstream sequence was placed 5' to the chloramphenicol acetyltransfer
ase reporter gene and transfected into MDA-MB-468 human breast cancer
cells, it directed chloramphenicol acetyltransferase expression in an
orientation specific manner, suggesting that this region contains elem
ents essential for IGFBP-5 promoter activity.